Sort
48,018 grants matching “immunotherapy”
PEDIATRIC AIDS CLINICAL TRIALS UNIT
$891,225Duke University · U01 · FY2001 · AI
BASE TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND ENDPOINT BIOMARKERS; TASK ORDER TITLE: EFGR AND KRAS VACCINE
$890,873Chinthalapally V. Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2020 · CA
Phase II Clinical Trial of G207 HSV To Treat Children with High Grade Gliomas
$890,765George Yancey Gillespie · Treovir, Inc · R44 · FY2023 · CA
PHILADELPHIA PEDIATRIC AIDS CLINICAL TRIALS UNIT
$890,498Children'S Hospital Of Philadelphia · U01 · FY2001 · AI
Cancer Immunotherapy Clinical Trials
$890,340Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
$889,638Roger L Shapiro · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2025 · AI
Immunology of aging and immunotherapy of aging-associated diseases
$889,306Arya Biragyn · National Institute On Aging · ZIA · FY2014 · AG
Next Generation Cancer Immunotherapies to Defeat Melanoma
$889,199Antoni Ribas · University Of California Los Angeles · R35 · FY2024 · CA
Visualization hub for genomics data exploration and translational discovery
$889,043Jingchun Zhu · University Of California Santa Cruz · U24 · FY2016 · CA
Regulation of RANTES expression in T lymphocytes
$888,707Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Function of granulysin
$888,707Alan Krensky · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Identification of Lethal Melanomas at the Time of Diagnosis
$888,702Nancy E Thomas · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Development of MTX-211 for the Treatment of KRAS Mutant Colorectal Cancer
$888,572Christopher Emil Whitehead · Mekanistic Therapeutics, Llc · R44 · FY2019 · CA
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
$888,461Donald L Sodora · Seattle Children'S Hospital · R01 · FY2022 · AI
Identification of human tumor-associated antigens
$887,872Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Clinical Support
$887,848James J Vredenburgh · Duke University · P01 · FY2014 · CA
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
$887,400John F Dipersio · Washington University · R35 · FY2019 · CA
Role of local antibodies in control of chronic genital herpes
$887,376Anton M Sholukh · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients
$887,145Angus W Thomson · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · AI
Targeted Therapy for Leukemia
$886,697John C Byrd · Ohio State University · R35 · FY2019 · CA
Cell Production Core Facility
$886,634Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Cell Prep Core
$886,633John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Rapid disease progression and viral reservoir formation in SIV-infected infant macaques
$886,371Donald L Sodora · Seattle Children'S Hospital · R01 · FY2023 · AI
Enhancing Antibody-directed Innate Immunity to Improve Cancer Outcome
$886,301Paul M Sondel · University Of Wisconsin-Madison · R35 · FY2019 · CA
Clinical Development of Immunotherapies for Rare Hematologic Maligancies
$886,293Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA